The epidemiology of urinary tract infection | 2010/12/01 | English | 959 |
Epidemiology and risk factors for kidney cancer | 2010/05/01 | English | 888 |
The genetic basis of kidney cancer: a metabolic disease | 2010/05/01 | English | 495 |
Oxidative stress and male infertility | 2017/05/16 | English | 463 |
The mechanism of action of BCG therapy for bladder cancer—a current perspective | 2014/02/04 | English | 443 |
Genetics of male infertility | 2018/04/05 | English | 430 |
Current use of PSMA–PET in prostate cancer management | 2016/02/23 | English | 416 |
The microbiome of the urinary tract—a role beyond infection | 2015/01/20 | English | 368 |
Clinical implications of PTEN loss in prostate cancer | 2018/02/20 | English | 358 |
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications | 2019/07/05 | English | 324 |
Metabolic regulation is important for spermatogenesis | 2012/05/01 | English | 298 |
Host–pathogen interactions in urinary tract infection | 2010/07/20 | English | 287 |
The inflammatory microenvironment and microbiome in prostate cancer development | 2017/10/31 | English | 278 |
The emerging threat of multidrug-resistant Gram-negative bacteria in urology | 2015/09/01 | English | 252 |
Mechanisms of BCG immunotherapy and its outlook for bladder cancer | 2018/07/10 | English | 248 |
The effect of obesity on sperm disorders and male infertility | 2010/02/16 | English | 242 |
A new era: artificial intelligence and machine learning in prostate cancer | 2019/05/15 | English | 238 |
Cellular plasticity and the neuroendocrine phenotype in prostate cancer | 2018/02/20 | English | 237 |
WNT signalling in prostate cancer | 2017/09/12 | English | 221 |
The emerging role of extracellular vesicles as biomarkers for urogenital cancers | 2014/11/18 | English | 218 |
Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol | 2017/10/31 | English | 208 |
Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer | 2014/06/24 | English | 206 |
Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers | 2014/08/01 | English | 205 |
Wnt/β-catenin signalling in prostate cancer | 2012/06/19 | English | 203 |
Genomic and phenotypic heterogeneity in prostate cancer | 2020/12/16 | English | 197 |
Multiparametric MRI for prostate cancer diagnosis: current status and future directions | 2019/07/17 | English | 191 |
ETS gene fusions in prostate cancer | 2009/08/01 | English | 190 |
Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations | 2016/10/11 | English | 188 |
An overview of kidney stone imaging techniques | 2016/08/31 | English | 185 |
Sexual dysfunction and male infertility | 2018/03/13 | English | 185 |